Xcout Intel
Alkeus
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing treatments that preserve the sight of individuals impacted by severe eye diseases.
Subscribe to see Alkeus’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Alkeus at a glance
Alkeus is a biotech company headquartered in United States. Xcout tracks 10 named people at Alkeus, including Michel Dahan (President and Chief Executive Officer). Xcout recorded 2 job postings from Alkeus in the last 90 days.
Alkeus leadership
- Michel DahanPresident and Chief Executive Officer
- David ArkowitzChief Financial Officer
- Carlos Quezada-RuizChief Medical Officer
- Eric L. TrachtenbergChief Legal Officer
- Seemi KhanChief Development and Strategy Officer
- Leonide SaadCo-Founder and Director
4 more named people on record for Alkeus, with roles, board committees and tenure — see the full roster →
Hiring at Alkeus
Xcout recorded 2 job postings from Alkeus in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Alkeus's hiring signals →
Recent Alkeus news
Tech stack
Alkeus competitors
A few of Alkeus's closest competitors — see the full list of competitors and alternatives →
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The company works to deliver advanced retinal gene therapies to patients experiencing blindness.
Stargazer Pharmaceuticals, Inc. is a Boston-based biopharmaceutical company focused on developing novel treatments for rare eye diseases, including Stargardt disease. The company advances clinical-stage pharmaceutical candidates through specialized clinical trials.
Acucela is a biotechnology company developing ophthalmic therapeutics for retinal diseases, including age-related macular degeneration and Stargardt disease. Its research has included visual-cycle modulators such as emixustat, aimed at treating degenerative eye conditions.
Graybug Vision, Inc. is a clinical-stage biopharmaceutical company headquartered in Redwood City, California, with additional offices in Baltimore, Maryland, focused on developing medicines for ocular diseases.
Aileron Therapeutics, Inc. is a clinical-stage biopharmaceutical company with principal executive offices located in Cambridge, Massachusetts. The company went public through a reverse merger and is involved in therapeutic acquisitions and development.
Lin BioScience is a clinical-stage biopharmaceutical company that discovers and develops novel, first-in-class drug candidates for the treatment of cancer, eye diseases, and metabolic diseases. The company serves patients with significant unmet medical needs through targeted therapies such as oral treatments for dry age-related macular degeneration, Stargardt disease, and acute leukemia.
Get Alkeus's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Alkeus in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access